
Overview
Filip Janku is a primary care provider, practicing in Internal Medicine in Houston, Texas. Dr. Janku is rated as an Advanced provider by MediFind in the treatment of Hodgkin Lymphoma. His top areas of expertise are Gastrointestinal Stromal Tumor, Colorectal Cancer, Lung Cancer, Cholangiocarcinoma (Bile Duct Cancer), and Tissue Biopsy.
His clinical research consists of co-authoring 284 peer reviewed articles and participating in 29 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 3 articles in the study of Hodgkin Lymphoma.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
29 Clinical Trials
Center For Cell And Gene Therapy
Dr. Kamble is Professor of Medicine in Hematology-Oncology, Cell and Gene Therapy, Baylor College of Medicine and Methodist Hospital, Houston, TX. He graduated from Ravi Shankar University, India in 1986 with a gold medal. He obtained postgraduate residency training from prestigious Postgraduate Institute of Medical Science and Research (PGIMER) Chandigarh, India and his fellowship training in Hematology-Oncology from All India Institute of Medical Sciences (AIIMS), New Delhi. He was junior faculty in the AIIMS before joining MAMC, New Delhi University as Assistant Professor of Medicine. Between 1997 and 2001, he completed his residency and fellowship training in Internal Medicine and Hematology-Oncology from University of Tennessee and University of Arkansas for Medical Sciences respectively. He has served as Assistant Professor of Medicine and Associate director of Hematology-Oncology fellowship program at Oklahoma University Health Sciences Center (OUHSC). Dr. Kamble is primarily interested in hematologic malignancies including multiple myeloma and hematopoietic stem cell transplantation. He was conferred Union against cancer (ICRETT, Geneva) award in 1994 to study molecular aspect of chronic myelogenous leukemia and bone marrow transplant in Hammersmith hospital, London and Central Science and Industrial Research (CSIR) award in 1995 to study stem cell transplantation in Cornell University, New York. Dr. Kamble is board certified in Internal Medicine and Medical Oncology. He has published extensively in prestigious journals including, Blood, Biology of Bone marrow transplantation and Journal of Clinical Oncology and regularly reviews manuscripts for Blood, Biology of bone marrow transplantation and Bone marrow transplant. Dr. Kamble's clinical interests are in innovative reduced conditioning protocols, in vivo T-cell depletion and novel approaches to reduce and treat graft-versus-host disease. Dr. Kamble is rated as a Distinguished provider by MediFind in the treatment of Hodgkin Lymphoma. His top areas of expertise are Multiple Myeloma, Graft Versus Host Disease (GvHD), Hodgkin Lymphoma, Bone Marrow Transplant, and Bone Graft.
MD Anderson
Paolo Strati is a primary care provider, practicing in Internal Medicine in Houston, Texas. Dr. Strati is rated as an Elite provider by MediFind in the treatment of Hodgkin Lymphoma. His top areas of expertise are Non-Hodgkin Lymphoma, B-Cell Lymphoma, Follicular Lymphoma, Tissue Biopsy, and Bone Marrow Aspiration.
Quan Le is a primary care provider, practicing in Internal Medicine in Houston, Texas. Dr. Le is rated as an Experienced provider by MediFind in the treatment of Hodgkin Lymphoma. Her top areas of expertise are Classical Hodgkin Lymphoma, Hodgkin Lymphoma, Tracheitis, and Avian Influenza.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Cholangiocarcinoma (Bile Duct Cancer)Dr. Janku isDistinguished. Learn about Cholangiocarcinoma (Bile Duct Cancer).
- Colorectal CancerDr. Janku isDistinguished. Learn about Colorectal Cancer.
- Erdheim-Chester DiseaseDr. Janku isDistinguished. Learn about Erdheim-Chester Disease.
- Gastrointestinal Stromal TumorDr. Janku isDistinguished. Learn about Gastrointestinal Stromal Tumor.
- Lung CancerDr. Janku isDistinguished. Learn about Lung Cancer.
- RhabdomyosarcomaDr. Janku isDistinguished. Learn about Rhabdomyosarcoma.
- Advanced
- ADULT SyndromeDr. Janku isAdvanced. Learn about ADULT Syndrome.
- Breast CancerDr. Janku isAdvanced. Learn about Breast Cancer.
- Castleman DiseaseDr. Janku isAdvanced. Learn about Castleman Disease.
- Classical Hodgkin LymphomaDr. Janku isAdvanced. Learn about Classical Hodgkin Lymphoma.
- Familial Colorectal CancerDr. Janku isAdvanced. Learn about Familial Colorectal Cancer.
- Gallbladder CancerDr. Janku isAdvanced. Learn about Gallbladder Cancer.
- Experienced
- Acute Interstitial PneumoniaDr. Janku isExperienced. Learn about Acute Interstitial Pneumonia.
- Anaplastic Thyroid CancerDr. Janku isExperienced. Learn about Anaplastic Thyroid Cancer.
- AnemiaDr. Janku isExperienced. Learn about Anemia.
- ChordomaDr. Janku isExperienced. Learn about Chordoma.
- Cytochrome C Oxidase DeficiencyDr. Janku isExperienced. Learn about Cytochrome C Oxidase Deficiency.
- DiarrheaDr. Janku isExperienced. Learn about Diarrhea.
